218 related articles for article (PubMed ID: 33152351)
41. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
Xiao Y; Gong D; Wang W
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
[TBL] [Abstract][Full Text] [Related]
42. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
[TBL] [Abstract][Full Text] [Related]
43. Docosahexaenoic acid inhibits monocrotaline-induced pulmonary hypertension via attenuating endoplasmic reticulum stress and inflammation.
Chen R; Zhong W; Shao C; Liu P; Wang C; Wang Z; Jiang M; Lu Y; Yan J
Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L243-L255. PubMed ID: 29097423
[TBL] [Abstract][Full Text] [Related]
44. Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters.
Wang D; Zhu ZL; Lin DC; Zheng SY; Chuang KH; Gui LX; Yao RH; Zhu WJ; Sham JSK; Lin MJ
Hypertension; 2021 Feb; 77(2):617-631. PubMed ID: 33356397
[TBL] [Abstract][Full Text] [Related]
45. Osthole improves pulmonary artery hypertension by inducing apoptosis in pulmonary artery smooth muscle cells.
Zhu L; Li YL; Qian ZQ; Hua L; Yue Y; Yang DL
J Pharm Pharmacol; 2021 Jul; 73(8):1109-1117. PubMed ID: 33988241
[TBL] [Abstract][Full Text] [Related]
46. Role of Src tyrosine kinases in experimental pulmonary hypertension.
Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
[TBL] [Abstract][Full Text] [Related]
47. The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension.
Yamaguchi Y; Hosokawa S; Haraguchi G; Kajikawa Y; Sakurai M; Ishii T; Ando N; Morio T; Doi S; Furukawa T
J Pharmacol Exp Ther; 2023 May; 385(2):88-94. PubMed ID: 36849413
[TBL] [Abstract][Full Text] [Related]
48. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
49. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
[TBL] [Abstract][Full Text] [Related]
50. Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation.
Wang G; Ma N; Meng L; Wei Y; Gui J
Mol Cell Biochem; 2015 Dec; 410(1-2):207-13. PubMed ID: 26350566
[TBL] [Abstract][Full Text] [Related]
51. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
52. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
53. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
54. Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
Xu T; Liu S; Ma T; Jia Z; Zhang Z; Wang A
Redox Biol; 2017 Apr; 11():286-296. PubMed ID: 28030785
[TBL] [Abstract][Full Text] [Related]
55. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
56. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
[TBL] [Abstract][Full Text] [Related]
57. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
58. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
[TBL] [Abstract][Full Text] [Related]
59. Ntsr1 contributes to pulmonary hypertension by enhancing endoplasmic reticulum stress via JAK2-STAT3-Thbs1 signaling.
Wei ZX; Cai XX; Fei YD; Wang Q; Hu XL; Li C; Hou JW; Yang YL; Wang YP; Li YG
Transl Res; 2024 Jul; 269():64-75. PubMed ID: 38395391
[TBL] [Abstract][Full Text] [Related]
60. Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
Tian X; Vroom C; Ghofrani HA; Weissmann N; Bieniek E; Grimminger F; Seeger W; Schermuly RT; Pullamsetti SS
PLoS One; 2011 Apr; 6(4):e18136. PubMed ID: 21494592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]